US Patent 7928064 Transgenically produced antithrombin III
Patent 7928064 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on April, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 14, 2005
Date of Patent
April 19, 2011
Patent Application Number
11284585
Patent Inventor Names
Paul DiTullio
0
Edward S. Cole
0
Harry M. Meade
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7928064 Transgenically produced antithrombin III
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.